Olsalazine

Olsalazine
Olsalazine
Systematic (IUPAC) name
5-[(2Z)-2-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazino]-2-hydroxybenzoic acid
Clinical data
Trade names Dipentum
AHFS/Drugs.com monograph
MedlinePlus a601088
Pregnancy cat. C(US)
Legal status -only (US)
Pharmacokinetic data
Protein binding 99%
Half-life 0.9 hours
Identifiers
CAS number 15722-48-2 YesY
ATC code A07EC03
PubChem CID 6003770
DrugBank DB01250
ChemSpider 10642377 YesY
UNII ULS5I8J03O YesY
KEGG D00727 N
ChEMBL CHEMBL571540 N
Chemical data
Formula C14H10N2O6 
Mol. mass 302.239g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Olsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease such as Ulcerative Colitis. It is sold under the name Dipentum.

The chemical name is 3,3' -azobis (6-hydroxybenzoate)salicylic acid. It is sold as the disodium salt.

Like Balsalazide, Olsalazine is believed to deliver Mesalazine, or 5-aminosalicylic acid (5-ASA), past the small intestine, directly to the large intestine, which is the active site of disease in ulcerative colitis.

Contents

History

Olsalazine gained Food and Drug Administration (FDA) approval in 1990.

Supply

The drug is supplied by UCB Pharma.

Other indications

The Australian biotech company Giaconda has developed a combination therapy for treating constipation-predominant Irritable Bowel Syndrome that uses olsalazine and the anti-gout drug colchicine.

External links